134 related articles for article (PubMed ID: 33823310)
1. MiR-34a/Sirt1/p53 signaling pathway contributes to cadmium-induced nephrotoxicity: A preclinical study in mice.
Hao R; Song X; Sun-Waterhouse D; Tan X; Li F; Li D
Environ Pollut; 2021 Aug; 282():117029. PubMed ID: 33823310
[TBL] [Abstract][Full Text] [Related]
2. microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway.
Jiang D; Li M; Yu Y; Shi H; Chen R
J Med Virol; 2019 Sep; 91(9):1643-1651. PubMed ID: 30968966
[TBL] [Abstract][Full Text] [Related]
3. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
4. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
[TBL] [Abstract][Full Text] [Related]
7. Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss.
Xiong H; Pang J; Yang H; Dai M; Liu Y; Ou Y; Huang Q; Chen S; Zhang Z; Xu Y; Lai L; Zheng Y
Neurobiol Aging; 2015 Apr; 36(4):1692-1701. PubMed ID: 25638533
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
Wu J; Liang W; Tian Y; Ma F; Huang W; Jia Y; Jiang Z; Wu H
J Cell Mol Med; 2019 May; 23(5):3538-3548. PubMed ID: 30793480
[TBL] [Abstract][Full Text] [Related]
9. Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis.
Alshehri AS; El-Kott AF; El-Kenawy AE; Khalifa HS; AlRamlawy AM
Sci Total Environ; 2021 Aug; 784():147182. PubMed ID: 34088068
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.
Yan S; Wang M; Zhao J; Zhang H; Zhou C; Jin L; Zhang Y; Qiu X; Ma B; Fan Q
Int J Mol Med; 2016 Jul; 38(1):201-9. PubMed ID: 27247228
[TBL] [Abstract][Full Text] [Related]
11. Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells.
Li LH; Tu QY; Deng XH; Xia J; Hou DR; Guo K; Zi XH
Brain Res; 2017 May; 1662():57-64. PubMed ID: 28189560
[TBL] [Abstract][Full Text] [Related]
12. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
14. Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model.
Reynolds RH; Petersen MH; Willert CW; Heinrich M; Nymann N; Dall M; Treebak JT; Björkqvist M; Silahtaroglu A; Hasholt L; Nørremølle A
Mol Cell Neurosci; 2018 Apr; 88():118-129. PubMed ID: 29289683
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
Hu Z; Fan H; Lv G; Zhou Q; Yang B; Zheng J; Cao W
J Dermatol Sci; 2015 Aug; 79(2):155-62. PubMed ID: 25982144
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a targets SIRT1 to reduce p53 deacetylation and promote sevoflurane inhalation anesthesia-induced neuronal autophagy and apoptosis in neonatal mice.
Xu X; Li C; Zou J; Liu L
Exp Neurol; 2023 Oct; 368():114482. PubMed ID: 37467842
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling.
Lin Y; Shen J; Li D; Ming J; Liu X; Zhang N; Lai J; Shi M; Ji Q; Xing Y
Gen Comp Endocrinol; 2017 May; 246():63-70. PubMed ID: 28263817
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.
Jiao D; Zhang H; Jiang Z; Huang W; Liu Z; Wang Z; Wang Y; Wu H
J Mol Med (Berl); 2018 Sep; 96(9):939-949. PubMed ID: 30030567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
